Clinical Trial Update: Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating evolocumab's effect on saphenous vein graft patency after coronary artery bypass surgery has completed. The study investigates whether …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Repatha (Evolocumab)

Snippet

Sponsor: Unity Health Toronto | Conditions: Coronary Artery Bypass Graft Surgery, Atherosclerosis | Phase 4 | Status: COMPLETED